AzTrials
AzTrials

Nutrition, HealthySwE4WEEKSNCT06656871

Biostimulants Application to Lettuce

A study testing iron supplementation and Biostimulated lettuce supplementation in people with Nutrition, Healthy and Glucose Metabolism Disorders, run by University of Palermo at 1 site in Italy.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Biostimulants application to vegetables is a useful agronomic approach to reduce the use of pesticides and to improve crop yield and quality by a naturally functionalizing process. Read more about this study

Who is it for?
Ages 20 to 70 yearsHealthy volunteers can take part
What is being tested?
iron supplementation and Biostimulated lettuce supplementation
Type of treatment
Pill or oral medicine
Could I receive a placebo?
No, everyone receives an active treatment
How many people
55 participants
Where
1 siteItaly
Study dates
10 Jun 2023to 10 Sep 2023
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 20 to 70 years
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Age 20 - 70 years
  • Italian Ethnicity
  • Body mass index between 18.5 and 28.5 kg/m2
  • Clinically Healthy

Who cannot join

  • Chronic disease
  • Use of drugs
  • Pregnancy
  • Exogenous hormones
  • Breastfeeding
  • Use of supplements
  • sensitivity to lettuce

Trial locations and contacts

1 site in 1 country.

Italy1 site
  • NABbio, STEBICEF department

    Palermo, 90128

Other trials in Italy

About this study

Official title: Biostimulants Application to Vegetables

Biostimulants application to vegetables is a useful agronomic approach to reduce the use of pesticides and to improve crop yield and quality by a naturally functionalizing process. The aim of the study is to verify the effects of a nutritional intervention with lettuce Biostimulated by application of seaweed extracts derived from Ecklonia maxima (SwE) in a healthy population in order to assess influence on specific essential minerals like calcium, potassium iron, magnesium, phosphorous (Primary outcome) and metabolisms like glucose, lipid, iron homeostasis (Secondary outcome).

Read the detailed description

The present project aims to investigate the benefits of biostimulants lettuce in a cohort of healthy individuals. Biostimulants are organic and inorganic compounds or microorganisms that when applied to plants can enhance plants' growth, yield, and tolerance to stress. Seaweed extract treatment seems to enhance mineral concentration in crops. Participants will be fed with biostimulated lettuce or a tablet of iron daily in order to study the influence on hematological parameters.

A cohort of healthy subjects will be divided into a control group, receiving control lettuce, lettuce SwE group, receiving biostimulated lettuce and iron tablet group receiving iron bisglycinate (30 mg) supplement in tablet for a total of 4 weeks. Blood samples will be collected in specific tubes before (baseline) and after the nutritional intervention (T2). The group will eat 100 grams of Lettuce (control group) and 100 grams of SwE Biostimulated lettuce (intervention group lettuce) for 4 weeks (100 grams/daily) or a tablet of iron (intervention group iron tablet) and collect blood samples (serum and plasma) baseline, before starting the nutritional intervention and after 4 weeks (T2).

Each subject will be subjected to two venous blood samples taken at the beginning of the observation and at the end. The samples obtained will be transported in certified containers for the safe transport of biological samples, and, subsequently, processed by the experimenters at the laboratories of the Molecular Biology section of the University of Palermo. Serum and plasma will be obtained from each blood sample. All information thus obtained will be recorded in a database in which each person will be identified with a numerical code, in order to comply with current privacy regulations. Body weight, Barefoot standing height, Body mass index, Body composition will be measured in the different groups of study. Samples will be analyzed and compared for glucose, insulin, total cholesterol, HDL-cholesterol, LDL-cholesterol, triglycerides, Ferritin, Iron, transferrin, Magnesium, Calcium, Potassium, Phosphate, Potassium.

Statistical analysis plan:

Student t tests will be used to compare the baseline characteristics of the groups. Changes between baseline and follow-up will be analyzed by one-way ANOVA followed by Sidak post test. A P < 0.05 will be considered to be statistically significant by using appropriate software.

Being tested
iron supplementation, Biostimulated lettuce supplementation
Medical subject headings
Glucose Metabolism Disorders, Lipid Metabolism Disorders, Malnutrition

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • iron supplementationDietary supplement

    The iron tablet group received iron supplementation (30 mg, 1 tablet/day of iron) for 4 weeks

  • Biostimulated lettuce supplementationDietary supplement

    the intervention group SwE lettuce group received lettuce biostimulated with Ecklonia Maxima algae (SwE lettuce, 100 grams/day) daily for 4 weeks

Study groups in NCT06656871
Study groupRoleWhat they receive
Control groupNo interventionThe control group received lettuce (control lettuce 100 grams/day) that was without any biostimulation with Ecklonia Maxima algae but with the same characteristic of SwE lettuce (soil, water, harvesting time) for 4 weeks.
Biostimulated SwE lettuce intervention groupExperimentalThe SwE lettuce intervention group received lettuce biostimulated with Ecklonia Maxima algae (SwE lettuce, 100 grams/day) for 4 weeks
Receives: Dietary Supplement: Biostimulated lettuce supplementation
Iron tablet intervention groupExperimentalThe iron tablet intervention group received iron supplementation (30 mg, 1 tablet/day of iron) for 4 weeks
Receives: Dietary Supplement: iron supplementation

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Measurement of minerals concentration in participants

    Calcium (mg/dL), Phosphate (mg/dL), Magnesium (mg/dL) will be assessed in serum at baseline and after 4 weeks.

    Measured: 4 weeks

  2. Measurement of iron concentration in participants

    Iron (μg/dL) will be assessed in serum at baseline and after 4 weeks.

    Measured: 4 weeks

  3. Measurement of Potassium concentration in participants

    Potassium (mmol/L) will be assessed in serum at baseline and after 4 weeks.

    Measured: 4 weeks

Secondary outcomes (6)
  1. Measurement of ferritin in participants

    Ferritin (ng/dL) will be measured in serum at baseline and after 4 weeks

    Measured: 4 weeks

  2. Measurement of lipid metabolism markers in participants

    triglicerises, HDL, LDL, cholesterol (in mg/dL) will be measured in serum at baseline and after 4 weeks

    Measured: 4 weeks

  3. Measurement of insulin in participants

    insulin (mUI/L) will be measured in serum at baseline and after 4 weeks

    Measured: 4 weeks

  4. Measurement of transferrin in participants

    transferrin (mg/dL) will be measured in serum at baseline and after 4 weeks

    Measured: 4 weeks

  5. Measurement of % saturation of transferrin in participants

    % saturation of transferrin will be measured in serum at baseline and after 4 weeks

    Measured: 4 weeks

  6. Measurement of glucose in participants

    glucose (mg/dL) will be measured in serum at baseline and after 4 weeks

    Measured: 4 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted24 Oct 2024
  2. Study start10 Jun 2023
  3. Primary completion10 Jul 2023
  4. Study completion10 Sep 2023

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Masking
Triple blind
Who is masked
Participant, Investigator, Outcomes assessor
Enrolment
55 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06656871
Sponsor's protocol ID
SwE4WEEKS23
Acronym
SwE4WEEKS
Status last verified
Mar 2023
First submitted
19 Oct 2024
Last updated
24 Oct 2024
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: Because is forbidden by the Italian Low

Publications

  • ttps://www.mdpi.com/2073-4395/12/6/1361 Description: Plant-Derived Biostimulants Differentially Modulate Primary and Secondary Metabolites and Improvethe Yield Potential of Red and Green Lettuce Cultivars

  • Di Gaudio F, Vasto S, Sabatino L, Ferrantelli V, Macaluso A, Caldarella R, Di Rosa L, Caldara GF, Proia P, Baldassano S. Consumption of lettuce with seaweed extract biostimulant application improved iron homeostasis in a randomized interventional trial of healthy individuals. Sci Rep. 2025 Mar 6;15(1):7799. doi: 10.1038/s41598-025-91380-7.

    PubMed 40050333

Questions about this trial

What is this clinical trial studying?

A study testing iron supplementation and Biostimulated lettuce supplementation in people with Nutrition, Healthy and Glucose Metabolism Disorders, run by University of Palermo at 1 site in Italy.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 24 Oct 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Italy. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Measurement of minerals concentration in participants (time frame: 4 weeks). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT06656871, which also lists 2 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 24 Oct 2024.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in